Call for Pharmac to Widen Proposed Criteria for Shingrix Funding
Pharmac announced, in February, it was looking to extend funded access to Shingrix, the new vaccination for shingles, to immunocompromised people over 18 years old. However, the proposal listed specific treatments and conditions eligible. While we were pleased to see people who are pre- or post-haematopoietic stem cell transplant included, we were disappointed that MS […]